Doctor profile · Federal record

Dr. Tarsha Rivens, MPAS PAC

Medical Physician Assistant (CMS: Physician Assistant) · Physician Assistant · Medical Physician Assistant · Cary, NC

  • NPI 1972775328
  • Accepts Medicare
  • MIPS 84.7 / 100 · 2023
  • 20 yrs in practice
  • Licensed in 2 states
  • Female
  • Group practice
  • No sanctions

Practice & contact

Operates at 3 locations .

NPPES Updated May 11, 2026
Primary practice
101 Sw Cary Pkwy Ste 210
Cary, NC 275115588
(919) 467-8556
Additional location
350 Pine State St
Lillington, NC 275469428
(910) 893-9700
fax (910) 893-9747
Additional location
1524 McHenry Ave Ste 470
Modesto, CA 953504572
(209) 578-5072
fax (209) 578-5292
Mailing address
4250 Woodlake Pl Apt 103
Raleigh, NC 276077540

Credentials & registration

NPPES · NUCC
NPI registered
March 2008 — 18 yrs on file
Profile last updated
December 6, 2024
Year of graduation
2006 — 20 yrs since
Specialty taxonomy
363AM0700X — NUCC code
State licenses (2)
North Carolina #0010-00834 · California #60726

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1972775328. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
1,461
Distinct HCPCS
10
Medicare allowed
$73,550
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 500 116 $5
99213 Established patient office or other outpatient visit, 20-29 minutes 275 250 $73
17000 Destruction of precancer skin growth, 1 growth 195 170 $43
17110 Destruction of skin growth, 1-14 growths 121 93 $88
99214 Established patient office or other outpatient visit, 30-39 minutes 103 89 $103
11102 Biopsy of related skin growth, first growth 74 69 $74
99203 New patient office or other outpatient visit, 30-44 minutes 44 44 $90
99212 Established patient office or other outpatient visit, 10-19 minutes 44 35 $45
17004 Destruction of precancer skin growth, 15 or more growths 29 26 $135
99204 New patient office or other outpatient visit, 45-59 minutes 24 24 $135

In context: peer comparison

Among 11 peers in this city , average services per provider: 90. This provider delivers 16× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,517
Transactions
85
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Janssen Biotech, Inc. 9 $452.06
PFIZER INC. 14 $399.24
E.R. Squibb & Sons, L.L.C. 10 $305.96
ABBVIE INC. 13 $280.83
SUN PHARMACEUTICAL INDUSTRIES INC. 11 $267.02
Arcutis Biotherapeutics, Inc. 5 $201.36
Amgen Inc. 4 $115.85
GENZYME CORPORATION 3 $112.97
Lilly USA, LLC 5 $80.60
Regeneron Healthcare Solutions, Inc. 3 $70.12
Incyte Corporation 2 $54.13
Galderma Laboratories, L.P. 2 $37.30
Organogenesis Inc. 1 $35.83
Dermavant Sciences, Inc. 2 $33.52
Boehringer Ingelheim Pharmaceuticals, Inc. 1 $27.15

By nature of payment

Food and Beverage
$2,343
Education
$174

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
187
Patients
132
Total drug cost
$9,184
Drug Type Claims Patients Total cost
Triamcinolone Acetonide Generic 47 36 $465
Fluorouracil Generic 38 36 $3,191
Mupirocin Generic 28 24 $217
Clobetasol Propionate Generic 27 23 $3,040
Ketoconazole Generic 20 13 $811
Metronidazole Generic 14 0 $934
Clindamycin Phosphate Generic 13 0 $525

Frequently asked questions

Auto-generated from federal data
What is Dr. Tarsha Rivens's medical specialty?
Dr. Tarsha Rivens practices Medical Physician Assistant in Cary, NC.
Where does Dr. Tarsha Rivens practice?
Dr. Tarsha Rivens practices at 101 Sw Cary Pkwy Ste 210, Cary, NC 275115588. Office phone: 9194678556.
What is Dr. Tarsha Rivens's NPI?
Dr. Tarsha Rivens's National Provider Identifier (NPI) is 1972775328, issued by NPPES.
Does Dr. Tarsha Rivens accept Medicare assignment?
Yes. Dr. Tarsha Rivens accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Tarsha Rivens commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.